What Astromech does
Astromech is an artificial intelligence startup developing models that predict biological change, SiliconANGLE reported in August 2026.[1] Astromech's model combines genomic, evolutionary, biological and functional data to anticipate how living systems will change over time.[1] The company says it is building a "Large Life Model," an AI system "purpose-built to decode the regulatory and evolutionary logic of biology."[2] Astromech's first public demonstration maps 46 longevity-associated genes across a time-calibrated tree of life, The Next Web reported.[3] Astromech describes itself as being in a deep research and development phase, and it plans pilot projects with partners in health and biosecurity.[3],[1]
Is this your company? Get featured or correct your listing →
Key Metrics
Company Snapshot
Astromech is a Biotech company. Latest valuation $3.8B (As of Aug 20, 2026, SiliconANGLE). Total funding $60M (As of Aug 20, 2026).
Recent changes
- Aug 20, 2026Aug 20, 2026Raised $20M Undisclosed at a $3.8B valuation SiliconANGLE
- Aug 20, 2026Aug 20, 2026First reported valuation: $3.8B SiliconANGLE
- Aug 20, 2026Aug 20, 2026First reported total funding: $60M SiliconANGLE
- Aug 20, 2026Aug 20, 2026New investor: NeoGenesis Capital SiliconANGLE
- Aug 20, 2026Aug 20, 2026Colossal Spinout Astromech Hits $3.8B on Biology AI Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Aug 20, 2026 | Undisclosed | $20M | $3.8B | SiliconANGLE |
How Astromech has been funded
Astromech was spun out of Colossal Biosciences and was established in September 2025.[1],[4] In August 2026, Astromech raised $20 million at a $3.8 billion valuation in a round led by biotechnology investor Bob Nelsen, SiliconANGLE reported.[1] Peak 6, NeoGenesis Capital, Builders VC and CAZ Investments joined the August 2026 round, which brought Astromech's total funding to $60 million.[1],[3]
Investors
Latest Pulse
- Aug 20, 2026Colossal Spinout Astromech Hits $3.8B on Biology AIAstromech, a Colossal Biosciences spinout co-founded by Ben Lamm and George Church, raised $20M at a $3.8B valuation to build AI models that predict evolutionary biological change.→
- Jul 20, 2026Colossal Biosciences in Talks to Raise at Up to $30B ValuationColossal Biosciences is reportedly in talks to raise new capital at a $20-30 billion valuation, up to triple its January 2025 mark, building revenue-generating spinouts beyond its mammoth and dire wolf projects.→
Coverage Timeline
newest firstAll Coverage
Value Add Research
Related Companies
Astromech FAQ
What is Astromech's valuation?
Astromech was valued at $3.8 billion after raising $20 million in August 2026, SiliconANGLE reported.[1]
How much revenue does Astromech make?
Astromech has not publicly disclosed revenue and describes itself as in a deep research and development phase; its most recent round was $20 million at a $3.8 billion valuation in August 2026.[3],[1]
How much has Astromech raised?
Astromech has raised $60 million in total, including the $20 million round led by Bob Nelsen in August 2026.[1]
Who invested in Astromech?
Bob Nelsen led Astromech's August 2026 round, with Peak 6, NeoGenesis Capital, Builders VC and CAZ Investments participating.[1]
Who founded Astromech?
Astromech was co-founded by Ben Lamm, CEO of Colossal Biosciences, and geneticist George Church, and was spun out of Colossal.[1],[4]
Is Astromech a public company?
No; Astromech raised a private $20 million round in August 2026, so it is privately held as of that date.[1]
References
researched 2026-10-19Sources & methodologyshow
Where these figures come from
- SiliconANGLEmajor outlet3 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.